SFI
VTAK icon

Susquehanna Fundamental Investments’s Catheter Precision VTAK Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$13K Hold
3
– – ﹤0.01% 1516
2021
Q4 		$51K Sell
3
-1
-25% -$23.8K ﹤0.01% 1367
2021
Q3 		$112K Buy
+4
New +$126K ﹤0.01% 1613

Other funds holding VTAK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Susquehanna Fundamental Investments's VTAK Position: Q1 2022 in Review

Susquehanna Fundamental Investments held its Catheter Precision (VTAK) position steady in Q1 2022 at 3 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Susquehanna Fundamental Investments first reported a position in VTAK in Q3 2021 and has held it in 3 quarters since. The position peaked at $112K in Q3 2021. 20 funds tracked by Wall St. Rank hold VTAK as of Q1 2022.

  • Susquehanna Fundamental Investments held 3 shares of Catheter Precision worth $13K as of Q1 2022.
  • Susquehanna Fundamental Investments left its Catheter Precision share count unchanged in Q1 2022.
  • Catheter Precision made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1516 holding.
  • Susquehanna Fundamental Investments first reported a position in Catheter Precision in Q3 2021 and has held it in 3 quarters since.
  • Susquehanna Fundamental Investments's Catheter Precision position peaked at $112K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.